Pfizer (PFE) Stock Premarket Today, Dec. 11, 2025: Marshall Wace Exit, Obesity Drug Deals and 2026 Guidance in Focus
Pfizer (NYSE: PFE) heads into Thursday’s session with its share price hovering around yesterday’s close, as investors digest a flurry of news on cost cuts, obesity drug deals, and a big hedge fund trimming its stake. As of around 6:05 a.m. ET on Thursday, December 11, real‑time feeds put Pfizer stock near $25.78, roughly flat versus Wednesday’s close of $25.78 after a 1.78% gain in the prior session.StockAnalysis+1 The stock has traded between $20.92 and $27.69 over the past 12 months, and daily volume on Wednesday was around 43–44 million shares, close to its recent average.Investing.com+1 Despite its recent rebound,